Full Length Research Paper
References
|
Afolayan J (2012). Knowledge and Use of Performance Enhancing Drugs Among Nigeria Elite Athletes. IOSR Journal of Applied Chemistry 1(5):31-38. |
|
|
Ahmed R, Sulaiman K, Hasan M, Dauod A (2021). Anabolic-androgenic steroid use among bodybuilders in Erbil city. Zanco Journal of Medical Sciences 25(3):657-665. |
|
|
Ajayi-Vincent OB, Olanipekun JA (2014). An Assessment of Prohibited Methods of Doping among Athletes in Tertiary Institutions in Southwest , Nigeria. Kuwait Chapter of Arabian Journal of Business and Management Review 3(5):60-65. |
|
|
Akindutire IO, Adegboyega JA, Olanipekun JA (2012). Doping Knowledge and Practice among Elite Athletes in Tertiary Institutions in Nigeria. European Scientific Journal 8(4). |
|
|
Albano GD, Amico F, Cocimano G, Liberto A, Maglietta F, Esposito M, Rosi GL, Di Nunno N, Salerno M, Montana A (2021). Review adverse effects of anabolic-androgenic steroids: A literature review. Healthcare (Switzerland) 9(1):1-19. |
|
|
Aldarweesh HH, Alhajjaj AH (2020). Anabolic androgenic steroid use prevalence, knowledge, and practice among male athletes in eastern province of Saudi Arabia. Electronic Journal of General Medicine 17(2):5-20. |
|
|
Alharbi FF, Gamaleddin I, Alharbi S F, Almodayfer O, Allohidan F, Alghobain M, … Al-Surimi K (2019). Knowledge, attitudes and use of anabolic-androgenic steroids among male gym users: A community based survey in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal 27(2):254-263. |
|
|
Althobiti S, Alqurashi, N, Alotaibi A, Alharthi T, Alswat K (2018). Prevalence, Attitude, Knowledge, and Practice of Anabolic Androgenic Steroid (AAS) Use Among Gym Participants. Materia Socio Medica 30(1):49. |
|
|
Angoorani H, Jalali M, Halabchi F (2018). Anabolic-Androgenic Steroids and Prohibited Substances Misuse among Iranian Recreational Female Bodybuilders and its Associated Psycho-socio-demographic Factors. Addiction and Health 10(4):216-222. View |
|
|
Bahri A, Mahfouz MS, Marran NM, Dighriri YH, Alessa HS, Khwaji MO, Zafar SM (2017). Prevalence and awareness of anabolic androgenic steroid use among male body builders in Jazan, Saudi Arabia. Tropical Journal of Pharmaceutical Research 16(6):1425-1430. |
|
|
Ball LJ, Puka K, Speechley M, Wong R, Hallam B, Wiener JC, Koivu S, Silverman MS (2019). Sharing of Injection Drug Preparation Equipment Is Associated with HIV Infection: A Cross-sectional Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 81(4):e99-e103. |
|
|
Bates G, Van Hout MC, Teck JTW, McVeigh J (2019). Treatments for people who use anabolic androgenic steroids: A scoping review. Harm Reduction Journal 16(1):1-15. |
|
|
Bonnecaze AK, O'Connor T, Aloi JA (2020). Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men. American Journal of Men's Health 14(6). |
|
|
Creagh S, Warden D, Latif MA, Paydar A (2018). The new classes of synthetic illicit drugs can significantly harm the brain: a neuro imaging perspective with full review of MRI findings. Clinical Radiology and Imaging Journal 2(1). |
|
|
Dandoy C, Gereige RS (2012). Performance-enhancing drugs. Pediatrics in Review 33(6):265-272. |
|
|
Denham BE (2019). Anabolic Steroid Cases in United States District Courts (2013-2017): Defendant Characteristics, Geographical Dispersion, and Substance Origins. Contemporary Drug Problems46(1):41-57. |
|
|
Halabchi F, Shab-Bidar S, Selk-Ghaffari M (2021). Prevalence of Supplement Consumption in Iranian Athletes: A Systematic Review and Meta-Analysis. International Journal of Preventive Medicine 12(1):1120-1134. |
|
|
Halliburton AE, Fritz MS (2018). Health beliefs as a key determinant of intent to use anabolic-androgenic steroids (AAS) among high-school football players: implications for prevention. International Journal of Adolescence and Youth 23(3):269-280. |
|
|
Handelsman DJ. (2021). Androgen Misuse and Abuse. Endocrine Reviews 42(4):457-501. |
|
|
Havnes IA, Jørstad ML, Wisløff C (2019). Anabolic-androgenic steroid users receiving health-related information; Health problems, motivations to quit and treatment desires. Substance Abuse: Treatment, Prevention and Policy 14(1):1-12. |
|
|
Hearne E, Wazaify M, Van Hout MC, Atkinson A, McVeigh,J (2021). Anabolic-Androgenic Steroid Use in the Eastern Mediterranean Region: a Scoping Review of Extant Empirical Literature. International Journal of Mental Health and Addiction 19(4):1162-1189. |
|
|
IBM Corp. Released (2012). IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp |
|
|
Ijadunola MY, Odia BO, Adepoju OA, Igwe K., James AO, Koyenikan YO, Inyang UJ, Kabiawu, BA. (2018). Perception of Nigeria university athletes about performance-enhancing substances and drug testing. International Journal of Sport Policy and Politics 10(3):567-78. |
|
|
Iraki J, Fitschen P, Espinar S, Helms E (2019). Nutrition recommendations for bodybuilders in the off-season: A narrative review. Sports 7(7):1-19. |
|
|
Kanayama G, Hudson JI, Pope HG (2020). Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians. Psychotherapy and Psychosomatics 89(2):65-73. |
|
|
Mazzeo F (2018). Anabolic steroid use in sports and in physical activity: Overview and analysis. Sport Montoring 16(3):113-118. |
|
|
Obafemi Awolowo University (2022). About OAU. |
|
|
Olorunsola HK (n.d.). Sports in Obafemi Awolowo University. |
|
|
Pereira E, Moyses SJ, Ignácio SA, Mendes DK, da Silva DS, Carneiro E, Hardy AM, Rosa EA, Bettega PV, Johann AC. (2019). Anabolic steroids among resistance training practitioners. PLoS ONE 14(10):1-13. |
|
|
Reardon CL, Hainline B, Aron CM, Baron D, Baum AL, Bindra A, Budgett R, Campriani N, Castaldelli-Maia JM, Currie A, Derevensky JL. (2019). Mental health in elite athletes: International Olympic Committee consensus statement (2019). British Journal of Sports Medicine 53(11):667-699. |
|
|
Sagoe D (2015). Nonmedical Ananbolic-Androgenic Steroid Use: prevalence, Attitudes and Social Perception. 1-90. |
|
|
Shah J, Janssen E, Le Nézet O, Spilka S (2019). Doping among high school students: Findings from the French ESPAD survey. European Journal of Public Health 29(6):1135-1140. |
|
|
Tauchen J., Jurášek M, Huml L, Rimpelová S (2021). Medicinal use of testosterone and related steroids revisited. Molecules 26(4):1-20. |
|
|
Torrisi M, Pennisi G, Russo I, Amico F, Esposito M, Liberto A, … Montana A (2020). Sudden cardiac death in anabolic-androgenic steroid users: A literature review. Medicina (Lithuania) 56(11):1-19. |
|
|
van de Ven K, Zahnow, R, McVeigh J, Winstock, A (2020). The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked? Drugs: Education, Prevention and Policy 27(2):131-135. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
